Federal (United States) · Session law
Title XI
31 sections
31 sections
- Pub. L. 112-144, tit. XI, subtit. A, sec. 1101REAUTHORIZATION OF PROVISION RELATING TO EXCLUSIVITY OF CERTAIN DRUGS CONTAINING SINGLE ENANTIOMERS.Enacted
- Pub. L. 112-144, tit. XI, subtit. A, sec. 1102REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE PARTNERSHIPS.Enacted
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1111REGULATION OF MEDICAL GASES.Enacted
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1112CHANGES TO REGULATIONS.Enacted
- Pub. L. 112-144, tit. XI, subtit. B, sec. 1113RULES OF CONSTRUCTION.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1121GUIDANCE DOCUMENT REGARDING PRODUCT PROMOTION USING THE INTERNET.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1122COMBATING PRESCRIPTION DRUG ABUSE.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1123OPTIMIZING GLOBAL CLINICAL TRIALS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1124ADVANCING REGULATORY SCIENCE TO PROMOTE PUBLIC HEALTH INNOVATION.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1125INFORMATION TECHNOLOGY.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1126NANOTECHNOLOGY.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1127ONLINE PHARMACY REPORT TO CONGRESS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1128REPORT ON SMALL BUSINESSES.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1129PROTECTIONS FOR THE COMMISSIONED CORPS OF THE PUBLIC HEALTH SERVICE ACT.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1130COMPLIANCE DATE FOR RULE RELATING TO SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1131STRATEGIC INTEGRATED MANAGEMENT PLAN.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1132ASSESSMENT AND MODIFICATION OF REMS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1133EXTENSION OF PERIOD FOR FIRST APPLICANT TO OBTAIN TENTATIVE APPROVAL WITHOUT FORFEITING 180-DAY-EXCLUSIVITY PERIOD.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1134DEADLINE FOR DETERMINATION ON CERTAIN PETITIONS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1135FINAL AGENCY ACTION RELATING TO PETITIONS AND CIVIL ACTIONS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1136ELECTRONIC SUBMISSION OF APPLICATIONS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1137PATIENT PARTICIPATION IN MEDICAL PRODUCT DISCUSSIONS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1138ENSURING ADEQUATE INFORMATION REGARDING PHARMACEUTICALS FOR ALL POPULATIONS, PARTICULARLY UNDERREPRESENTED SUBPOPULATIONS, INCLUDING RACIAL SUBGROUPS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1139SCHEDULING OF HYDROCODONE.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1140STUDY ON DRUG LABELING BY ELECTRONIC MEANS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1141RECOMMENDATIONS ON INTEROPERABILITY STANDARDS.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1142CONFLICTS OF INTEREST.Enacted
- Pub. L. 112-144, tit. XI, subtit. C, sec. 1143NOTIFICATION OF FDA INTENT TO REGULATE LABORATORY-DEVELOPED TESTS.Enacted
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1151SHORT TITLE.Enacted
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1152ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.Enacted
- Pub. L. 112-144, tit. XI, subtit. D, sec. 1153TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.Enacted